Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Disclaimer: This document is for informational purposes only and is not intended as financial advice. Please consult with a financial advisor before making any investment decisions.
Investment Overview (As of April 27, 2024)
Shares Information:
Shares Float: 18.9 Million
Relative Volume (Rel. Vol): 3.08
Insider Activity:
Recent insider purchases noted, indicating potential confidence in the company’s future.
Upcoming Corporate Events:
Clinical Trials: Five trials scheduled for 2024.
Financial Health:
Strong liquidity position with substantial cash reserves and minimal debt.
Key Technical Levels:
Resistance Levels: Watch for $5.30, $6.30, $7.50, and $8.70. These points may offer opportunities for taking partial profits.
Trading Strategy:
Take Profit (TP): Set a profit target at approximately $11.00 to capitalize on earnings.
Stop Loss (SL): Establish a stop loss order below $4.00 to limit potential losses.
Chart Analysis:
For a comprehensive analysis of price actions and trends, refer to the attached chart.
Risk Advisory:
Investing involves substantial risks. It is crucial to evaluate market conditions and your personal risk tolerance carefully. Conduct thorough research or consult with a financial advisor before making any trading decisions.
Disclaimer: This document is for informational purposes only and is not intended as financial advice. Please consult with a financial advisor before making any investment decisions.
Investment Overview (As of April 27, 2024)
Shares Information:
Shares Float: 18.9 Million
Relative Volume (Rel. Vol): 3.08
Insider Activity:
Recent insider purchases noted, indicating potential confidence in the company’s future.
Upcoming Corporate Events:
Clinical Trials: Five trials scheduled for 2024.
Financial Health:
Strong liquidity position with substantial cash reserves and minimal debt.
Key Technical Levels:
Resistance Levels: Watch for $5.30, $6.30, $7.50, and $8.70. These points may offer opportunities for taking partial profits.
Trading Strategy:
Take Profit (TP): Set a profit target at approximately $11.00 to capitalize on earnings.
Stop Loss (SL): Establish a stop loss order below $4.00 to limit potential losses.
Chart Analysis:
For a comprehensive analysis of price actions and trends, refer to the attached chart.
Risk Advisory:
Investing involves substantial risks. It is crucial to evaluate market conditions and your personal risk tolerance carefully. Conduct thorough research or consult with a financial advisor before making any trading decisions.
코멘트:
hit 6.35
코멘트:
Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing
May 23, 202416:00 GMT+2
May 23, 202416:00 GMT+2